Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 2 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar pchop123 (79.41) Submitted: 11/14/2012 9:16:14 PM : Underperform Start Price: $20.73 INFI Score: -22.87

No bottom bounce expected

Featured Broker Partners


Advertisement